Who owns INHIBIKASE THERAPEUTICS INC?
- Ticker: IKT
- CUSIP Number: 45719w205
Tip: Access positions for across all investors
Analyze quarterly positions in Inhibikase Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inhibikase Therapeutics stock
Who bought or sold INHIBIKASE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 627k | $815k | 6% | Sep 2024 |
|
| William Blair $ Company | 126k | $164k | 9% | Sep 2024 |
|
| Geode Capital Management | 50k | $65k | 34% | Sep 2024 |
|
| Renaissance Technologies | 20k | $26k | -4% | Sep 2024 |
|
| Vanguard Group | 17k | $22k | 0% | Sep 2024 |
|
| State Street Corporation | 10k | $13k | 0% | Sep 2024 |
|
| UBS Group | 4.9k | $6.3k | 100% | Sep 2024 |
|
| Tower Research Capital | 4.1k | $5.3k | -29% | Sep 2024 |
|
| Wells Fargo & Company | 167.00 | $216.999800 | 0% | Sep 2024 |
|
| Bank of America Corporation | 53.00 | $69.000700 | 26% | Sep 2024 |
|
| Synergy Financial Management | 50.00 | $65.000000 | 100% | Dec 2024 |
|
Who sold out of Inhibikase Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2024 | 38k | $50k |